Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia
Open Access
- 1 September 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 32 (9), 2104-2112
- https://doi.org/10.1161/atvbaha.111.241463
Abstract
Insulin plays a central role in regulating energy metabolism, including hepatic transport of very low-density lipoprotein (VLDL)–associated triglyceride. Hepatic hypersecretion of VLDL and consequent hypertriglyceridemia leads to lower circulating high-density lipoprotein levels and generation of small dense low-density lipoproteins characteristic of the dyslipidemia commonly observed in metabolic syndrome and type 2 diabetes mellitus. Physiological fluctuations of insulin modulate VLDL secretion, and insulin inhibition of VLDL secretion upon feeding may be the first pathway to become resistant in obesity that leads to VLDL hypersecretion. This review summarizes the role of insulin–related signaling pathways that determine hepatic VLDL production. Disruption in signaling pathways that reduce generation of the second messenger phosphatidylinositide (3,4,5) triphosphate downstream of activated phosphatidylinositide 3-kinase underlies the development of VLDL hypersecretion. As insulin resistance progresses, a number of pathways are altered that further augment VLDL hypersecretion, including hepatic inflammatory pathways. Insulin plays a complex role in regulating glucose metabolism, and it is not surprising that the role of insulin in VLDL and lipid metabolism will prove equally complex.This publication has 106 references indexed in Scilit:
- p85α SH2 Domain Phosphorylation by IKK Promotes Feedback Inhibition of PI3K and Akt in Response to Cellular StarvationMolecular Cell, 2012
- The Scap/SREBP Pathway Is Essential for Developing Diabetic Fatty Liver and Carbohydrate-Induced Hypertriglyceridemia in AnimalsCell Metabolism, 2012
- mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP PathwayCell, 2011
- Acute suppression of apo B secretion by insulin occurs independently of MTPBiochemical and Biophysical Research Communications, 2011
- PTP1B: a double agent in metabolism and oncogenesisTrends in Biochemical Sciences, 2010
- From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locusNature, 2010
- Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinaseProceedings of the National Academy of Sciences of the United States of America, 2010
- Nonsynonymous Mutations within APOB in Human Familial Hypobetalipoproteinemia: EVIDENCE FOR FEEDBACK INHIBITION OF LIPOGENESIS AND POSTENDOPLASMIC RETICULUM DEGRADATION OF APOLIPOPROTEIN BOnline Journal of Public Health Informatics, 2010
- Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: A pathway for late-stage quality controlProceedings of the National Academy of Sciences of the United States of America, 2008
- Critical nodes in signalling pathways: insights into insulin actionNature Reviews Molecular Cell Biology, 2006